The reduced effectiveness of antibiotics risks severe disruption to the global economy
The lessons learnt from drug-resistant tuberculosis offer a path to beating back the ‘silent pandemic’ of antimicrobial resistance
Groups managing more than $13tn cite ‘economic imperative’ of finding ways to reduce superbugs’ spread
WHO reviews Niger trial as issue highlights dilemma over threat of ‘superbugs’
Wild birds are more likely to be carriers of antibiotic-resistant bacteria if they live close to humans, says study
Drugmakers will receive flat fees for new medicines in push to avoid encouraging overuse
Innovation prize targeting urinary tract infections boosts effort to tackle pathogens that develop immunity to drugs
GSK joins UK government in committing £130mn to tackle growth of antimicrobial resistance
Global warming, flooding and pollution could all help promote evolution of pathogens
Pfizer’s Emblaveo to be aimed at some of the most dangerous drug-resistant bacteria
New molecule proves effective in animals against several drug-resistant bacteria
Investing in new oncology drugs without building up an effective arsenal against infections is a false economy
Medical experts call for curbs on agricultural fungicides
Potential remedy targets leading antibiotic-resistant pathogen that causes life-threatening infections in patients
Economic and political fallout from war distracts governments from health threats
Unlearnt lessons of Covid; deficient world diagnostics; vaccine cold storage in the global south; stronger health surveillance systems needed; medical waste unmasked; doctors’ pay and the fight against disease; book review of the four decades since Aids
Drug resistance is not just a problem with bacteria
New model aims to reduce high development costs and increase number of drugs being tested
Shionogi chief warns companies are deserting the field to focus on more lucrative areas
Antimicrobial resistance already kills millions and is projected to get worse. But there is little incentive for Big Pharma to tackle the issue
As the antibiotic pipeline empties, a fresh approach to studying bacteria has emerged
Awareness about the negative impact of antimicrobial resistance on shareholder returns is growing
Health department to spend £210mn to track deadly superbugs across Asia and Africa
Research finds superbugs increase in tandem with levels of small particulate matter in the air
Successful pilot in England will be expanded to more pharma companies and include N Ireland, Scotland and Wales
